Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Lagerberg, Trine V ^a   Andreassen, Ole A ^a,b   Ringen, Petter A ^b   Berg, Akiah O ^b   Larsson, Sara ^b   Agartz, Ingrid ^b,c   Sundet, Kjetil ^b   Melle, Ingrid ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANXIOLYTIC AGENT; CANNABIS; HYPNOTIC AGENT; NEUROLEPTIC AGENT; STREET DRUG;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; DISEASE COURSE; EDUCATIONAL STATUS; EMPLOYMENT STATUS; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORWAY; OUTPATIENT; PATIENT COMPLIANCE; SCORING SYSTEM; SUBSTANCE ABUSE; SUICIDAL BEHAVIOR; UNIVERSITY HOSPITAL; ADDICTION; ADOLESCENT; AGE; ALCOHOLISM; CHILD; COMORBIDITY; COMPARATIVE STUDY; HOSPITALIZATION; MIDDLE AGED; PREVALENCE; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; QUESTIONNAIRE; RISK FACTOR; SEX DIFFERENCE; STATISTICS; SUICIDE ATTEMPT;

ADOLESCENT; ADULT; AGE FACTORS; ALCOHOLISM; BIPOLAR DISORDER; CHILD; COMORBIDITY; DIAGNOSIS, DUAL (PSYCHIATRY); DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; NORWAY; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; SUICIDE, ATTEMPTED;

EID: 77349097371     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-9     Document Type: Article

References (95)

1. Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264:2511-2518. 10.1001/jama.264.19.2511, 2232018.
2. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997, 54:313-321.
3. Grant BF, Stinson FS, Hasin DS, Dawson DA, Chou SP, Ruan WJ, et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2005, 66:1205-1215. 10.4088/JCP.v66n1001, 16259532.
4. Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 1996, 37:43-49. 10.1016/0165-0327(95)00080-1, 8682977.
5. Frye MA, Altshuler LL, McElroy SL, Suppes T, Keck PE, Denicoff K, et al. Gender differences in prevalence, risk, and clinical correlates of alcoholism comorbidity in bipolar disorder. Am J Psychiatry 2003, 160:883-889. 10.1176/appi.ajp.160.5.883, 12727691.
6. Chengappa KN, Levine J, Gershon S, Kupfer DJ. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disord 2000, 2:191-195. 10.1034/j.1399-5618.2000.020306.x, 11256686.
7. Conus P, McGorry PD. First-episode mania: a neglected priority for early intervention. Aust N Z J Psychiatry 2002, 36:158-172. 10.1046/j.1440-1614.2002.00994.x, 11982536.
8. Strakowski SM, Sax KW, McElroy SL, Keck PE, Hawkins JM, West SA. Course of psychiatric and substance abuse syndromes co-occurring with bipolar disorder after a first psychiatric hospitalization. J Clin Psychiatry 1998, 59:465-471.
9. Mueser KT, Drake RE, Wallach MA. Dual diagnosis: a review of etiological theories. Addict Behav 1998, 23:717-734. 10.1016/S0306-4603(98)00073-2, 9801712.
10. Goldstein BI, Velyvis VP, Parikh S. Does moderate alcohol use in bipolar disorder predict increased symptom severity and poorer functioning?. 2008, 1835.
11. Sbrana A, Bizzarri JV, Rucci P, Gonnelli C, Doria MR, Spagnolli S, et al. The spectrum of substance use in mood and anxiety disorders. Compr Psychiatry 2005, 46:6-13. 10.1016/j.comppsych.2004.07.017, 15714188.
12. Ringen PA, Melle I, Birkenaes AB, Engh JA, Faerden A, Jonsdottir H, et al. Illicit drug use in patients with psychotic disorders compared with that in the general population: a cross-sectional study. Acta Psychiatr Scand 2008, 117(2):133-8.
13. Ringen PA, Lagerberg TV, Birkenaes AB, Engn J, Faerden A, Jonsdottir H, et al. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. Psychol Med 2007, 1-9.
14. Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and signficiance of mixed affective states in a bipolar population. Arch Gen Psychiatry 1976, 33:1062-1066.
15. Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, et al. Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986, 255:3138-3142. 10.1001/jama.255.22.3138, 3702024.
16. Coryell W, Turvey C, Endicott J, Leon AC, Mueller T, Solomon D, et al. Bipolar I affective disorder: predictors of outcome after 15 years. J Affect Disord 1998, 50:109-116. 10.1016/S0165-0327(98)00043-3, 9858070.
17. Tohen M, Zarate CA, Zarate SB, Gebre-Mehdin P, Pike S. The McLean/Harvard First-Episode Mania Project: Pharmacologic Treatment and Outcome. Psychiatric Annals 1996, 26(7):S444-S448.
18. Goldberg JF, Garno JL, Leon AC, Kocsis JH, Portera L. A history of substance abuse complicates remission from acute mania in bipolar disorder. J Clin Psychiatry 1999, 60:733-740.
19. Bauer MS, Altshuler L, Evans DR, Beresford T, Williford WO, Hauger R. Prevalence and distinct correlates of anxiety, substance, and combined comorbidity in a multi-site public sector sample with bipolar disorder. J Affect Disord 2005, 85:301-315. 10.1016/j.jad.2004.11.009, 15780700.
20. Weiss RD, Ostacher MJ, Otto MW, Calabrese JR, Fossey M, Wisniewski SR, et al. Does recovery from substance use disorder matter in patients with bipolar disorder?. J Clin Psychiatry 2005, 66:730-735. 10.4088/JCP.v66n0609, 15960566.
21. van Rossum I, Haro JM, Tenback D, Boomsma M, Goetz I, Vieta E, et al. Stability and treatment outcome of distinct classes of mania. Eur Psychiatry 2008, 23:360-367. 10.1016/j.eurpsy.2008.02.005, 18434101.
22. Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002, 59:530-537. 10.1001/archpsyc.59.6.530, 12044195.
23. Tohen M, Waternaux CM, Tsuang MT, Hunt AT. Four-year follow-up of twenty-four first-episode manic patients. J Affect Disord 1990, 19:79-86. 10.1016/0165-0327(90)90012-W, 2142702.
24. Tohen M, Waternaux CM, Tsuang MT. Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990, 47:1106-1111.
25. Perlis RH, Ostacher MJ, Patel JK, Marangell LB, Zhang H, Wisniewski SR, et al. Predictors of recurrence in bipolar disorder: primary outcomes from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry 2006, 163:217-224. 10.1176/appi.ajp.163.2.217, 16449474.
26. Cardoso BM, Kauer SM, Dias VV, Andreazza AC, Cereser KM, Kapczinski F. The impact of co-morbid alcohol use disorder in bipolar patients. Alcohol 2008, 42:451-457. 10.1016/j.alcohol.2008.05.003, 18760714.
27. Goldstein BI, Levitt AJ. The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder. Bipolar Disord 2008, 10:67-78. 10.1111/j.1399-5618.2008.00584.x, 18199243.
28. Verduin ML, Carter RE, Brady KT, Myrick H, Timmerman MA. Health service use among persons with comorbid bipolar and substance use disorders. Psychiatr Serv 2005, 56:475-480. 10.1176/appi.ps.56.4.475, 15812100.
29. Haro JM, van OJ, Vieta E, Reed C, Lorenzo M, Goetz I. Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study. Acta Psychiatr Scand 2006, 113:112-120. 10.1111/j.1600-0447.2005.00692.x, 16423162.
30. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord 2003, 5:58-61. 10.1034/j.1399-5618.2003.00017.x, 12656940.
31. Morrison JR. Bipolar affective disorder and alcoholism. Am J Psychiatry 1974, 131:1130-1133.
32. Goldstein TR, Birmaher B, Axelson D, Ryan ND, Strober MA, Gill MK, et al. History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord 2005, 7:525-535. 10.1111/j.1399-5618.2005.00263.x, 16403178.
33. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Steinberg JL, Moeller FG. Increased impulsivity associated with severity of suicide attempt history in patients with bipolar disorder. Am J Psychiatry 2005, 162:1680-1687. 10.1176/appi.ajp.162.9.1680, 16135628.
34. Potash JB, Kane HS, Chiu YF, Simpson SG, MacKinnon DF, McInnis MG, et al. Attempted suicide and alcoholism in bipolar disorder: clinical and familial relationships. Am J Psychiatry 2000, 157:2048-2050. 10.1176/appi.ajp.157.12.2048, 11097977.
35. Comtois KA, Russo JE, Roy-Byrne P, Ries RK. Clinicians' assessments of bipolar disorder and substance abuse as predictors of suicidal behavior in acutely hospitalized psychiatric inpatients. Biol Psychiatry 2004, 56:757-763. 10.1016/j.biopsych.2004.10.003, 15556120.
36. Sublette EM, Carballo JJ, Moreno C, Galfalvy HC, Brent DA, Birmaher B, et al. Substance use disorders and suicide attempts in bipolar subtypes. J Psychiatr Res 2009, 43:230-238. 10.1016/j.jpsychires.2008.05.001, 2671238, 18590916.
37. Lopez P, Mosquera F, de LJ, Gutierrez M, Ezcurra J, Ramirez F, et al. Suicide attempts in bipolar patients. J Clin Psychiatry 2001, 62:963-966.
38. Tsai SY, Chen CC, Yeh EK. Alcohol problems and long-term psychosocial outcome in Chinese patients with bipolar disorder. J Affect Disord 1997, 46:143-150. 10.1016/S0165-0327(97)00099-2, 9479618.
39. Salloum IM, Cornelius JR, Mezzich JE, Kirisci L. Impact of concurrent alcohol misuse on symptom presentation of acute mania at initial evaluation. Bipolar Disord 2002, 4:418-421. 10.1034/j.1399-5618.2002.01194.x, 12519103.
40. MacKinnon DF, Zandi PP, Gershon E, Nurnberger JI, Reich T, DePaulo JR. Rapid switching of mood in families with multiple cases of bipolar disorder. Arch Gen Psychiatry 2003, 60:921-928. 10.1001/archpsyc.60.9.921, 12963674.
41. Khalsa HM, Salvatore P, Hennen J, Baethge C, Tohen M, Baldessarini RJ. Suicidal events and accidents in 216 first-episode bipolar I disorder patients: predictive factors. J Affect Disord 2008, 106:179-184. 10.1016/j.jad.2007.05.027, 17614135.
42. Baca-Garcia E, Sher L, Perez-Rodriguez MM, Burke AK, Sullivan GM, Grunebaum MF, et al. Treatment of depressed bipolar patients with alcohol use disorders: plenty of room for improvement. J Affect Disord 2009, 115:262-268. 10.1016/j.jad.2008.09.012, 2730967, 18973953.
43. Keck PE, McElroy SL, Strakowski SM, West SA, Sax KW, Hawkins JM, et al. 12-month outcome of patients with bipolar disorder following hospitalization for a manic or mixed episode. Am J Psychiatry 1998, 155:646-652.
44. Baldessarini RJ, Perry R, Pike J. Factors associated with treatment nonadherence among US bipolar disorder patients. Hum Psychopharmacol 2008, 23:95-105. 10.1002/hup.908, 18058849.
45. Manwani SG, Szilagyi KA, Zablotsky B, Hennen J, Griffin ML, Weiss RD. Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry 2007, 68:1172-1176. 10.4088/JCP.v68n0802, 17854240.
46. Sajatovic M, Ignacio RV, West JA, Cassidy KA, Safavi R, Kilbourne AM, et al. Predictors of nonadherence among individuals with bipolar disorder receiving treatment in a community mental health clinic. Compr Psychiatry 2009, 50:100-107. 10.1016/j.comppsych.2008.06.008, 19216885.
47. Goldstein BI, Strober MA, Birmaher B, Axelson DA, Esposito-Smythers C, Goldstein TR, et al. Substance use disorders among adolescents with bipolar spectrum disorders. Bipolar Disord 2008, 10:469-478. 10.1111/j.1399-5618.2008.00584.x, 2768482, 18452443.
48. Winokur G, Coryell W, Akiskal HS, Maser JD, Keller MB, Endicott J, et al. Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness, and the primary-secondary distinction. Am J Psychiatry 1995, 152:365-372.
49. Nolen WA, Luckenbaugh DA, Altshuler LL, Suppes T, McElroy SL, Frye MA, et al. Correlates of 1-year prospective outcome in bipolar disorder: results from the Stanley Foundation Bipolar Network. Am J Psychiatry 2004, 161:1447-1454. 10.1176/appi.ajp.161.8.1447, 15285972.
50. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis 1994, 182:349-352. 10.1097/00005053-199406000-00007, 8201307.
51. Ernst CL, Goldberg JF. Clinical features related to age at onset in bipolar disorder. J Affect Disord 2004, 82:21-27. 10.1016/j.jad.2003.10.002, 15465573.
52. McKowen JW, Frye MA, Altshuler LL, Gitlin MJ. Patterns of alcohol consumption in bipolar patients comorbid for alcohol abuse or dependence. Bipolar Disord 2005, 7:377-381. 10.1111/j.1399-5618.2005.00208.x, 16026491.
53. Schneck CD, Miklowitz DJ, Calabrese JR, Allen MH, Thomas MR, Wisniewski SR, et al. Phenomenology of rapid-cycling bipolar disorder: data from the first 500 participants in the Systematic Treatment Enhancement Program. Am J Psychiatry 2004, 161:1902-1908. 10.1176/appi.ajp.161.10.1902, 15465989.
54. Keller MB. Prevalence and impact of comorbid anxiety and bipolar disorder. J Clin Psychiatry 2006, 67(Suppl 1):5-7.
55. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001, 3:181-188. 10.1034/j.1399-5618.2001.30403.x, 11552957.
56. Pini S, Dell'Osso L, Mastrocinque C, Marcacci G, Papasogli A, Vignoli S, et al. Axis I comorbidity in bipolar disorder with psychotic features. Br J Psychiatry 1999, 175:467-471. 10.1192/bjp.175.5.467, 10789280.
57. Carter TD, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res 2003, 37:297-303. 10.1016/S0022-3956(03)00052-9, 12765852.
58. Sentissi O, Navarro JC, Oliveira HD, Gourion D, Bourdel MC, Bayle FJ, et al. Bipolar disorders and quality of life: The impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients. Psychiatry Res 2008, 161(1):36-42. 10.1016/j.psychres.2007.06.016, 18786727.
59. Salloum IM, Cornelius JR, Mezzich JE, Kirisci L, Daley DC, Spotts CR, et al. Characterizing female bipolar alcoholic patients presenting for initial evaluation. Addict Behav 2001, 26:341-348. 10.1016/S0306-4603(00)00109-X, 11436926.
60. Mazza M, Mandelli L, Di NM, Harnic D, Catalano V, Tedeschi D, et al. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. J Affect Disord 2009, 115:27-35. 10.1016/j.jad.2008.08.019, 18845344.
61. Singh J, Mattoo SK, Sharan P, Basu D. Quality of life and its correlates in patients with dual diagnosis of bipolar affective disorder and substance dependence. Bipolar Disord 2005, 7:187-191. 10.1111/j.1399-5618.2004.00173.x, 15762860.
62. Reich LH, Davies RK, Himmelhoch JM. Excessive alcohol use in manic-depressive illness. Am J Psychiatry 1974, 131:83-86.
63. Brady K, Casto S, Lydiard RB, Malcolm R, Arana G. Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 1991, 17:389-397. 10.3109/00952999109001598, 1746501.
64. Hoblyn JC, Balt SL, Woodard SA, Brooks JO. Substance use disorders as risk factors for psychiatric hospitalization in bipolar disorder. Psychiatr Serv 2009, 60:50-55. 10.1176/appi.ps.60.1.50, 19114570.
65. Bauer MS, Shea N, McBride L, Gavin C. Predictors of service utilization in veterans with bipolar disorder: a prospective study. J Affect Disord 1997, 44:159-168. 10.1016/S0165-0327(97)00046-3, 9241576.
66. O'Connell RA, Mayo JA, Flatow L, Cuthbertson B, O'Brien BE. Outcome of bipolar disorder on long-term treatment with lithium. Br J Psychiatry 1991, 159(123-9):123-129. 10.1192/bjp.159.1.123, 1888958.
67. Kusznir A, Cooke RG, Young LT. The correlates of community functioning in patients with bipolar disorder. J Affect Disord 2000, 61:81-85. 10.1016/S0165-0327(99)00193-7, 11099744.
68. Norwegian Institute of Drug and Alcohol Research (SIRUS) Det norske drikkemønsteret. SirusRapport nr 2/2007 2007, Statens Institutt for Rusmiddelforskning/Norwegian Institute for Alcohol and Drug Research (SIRUS), Norwegian Institute of Drug and Alcohol Research (SIRUS).
69. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington DC, USA: American Psychiatric Association, American Psychiatric Association.
70. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
71. Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med 1996, 26:477-486. 10.1017/S0033291700035558, 8733206.
72. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978, 133:429-435. 10.1192/bjp.133.5.429, 728692.
73. Endicott J, Spitzer RL, Fleiss JL, Cohen J. The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976, 33:766-771.
74. Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the Global Assessment of Functioning-Split version. Compr Psychiatry 2007, 48:88-94. 10.1016/j.comppsych.2006.03.008, 17145287.
75. Thompson K, Kulkarni J, Sergejew AA. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 2000, 42:241-247. 10.1016/S0920-9964(99)00130-9, 10785582.
76. Swann AC, Anderson JC, Dougherty DM, Moeller FG. Measurement of inter-episode impulsivity in bipolar disorder. Psychiatry Res 2001, 101:195-197. 10.1016/S0165-1781(00)00249-3, 11286822.
77. Nery FG, Hatch JP, Glahn DC, Nicoletti MA, Monkul ES, Najt P, et al. Temperament and character traits in patients with bipolar disorder and associations with comorbid alcoholism or anxiety disorders. J Psychiatr Res 2008, 42:569-577. 10.1016/j.jpsychires.2007.06.004, 2693238, 17675066.
78. Brady KT, Myrick H, McElroy S. The relationship between substance use disorders, impulse control disorders, and pathological aggression. Am J Addict 1998, 7:221-230. 10.3109/10550499808998354, 9702290.
79. Fergusson DM, Boden JM, Horwood LJ. The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study. Drug Alcohol Depend 2008, 96:165-177. 10.1016/j.drugalcdep.2008.03.003, 18423900.
80. Swann AC, Dougherty DM, Pazzaglia PJ, Pham M, Moeller FG. Impulsivity: a link between bipolar disorder and substance abuse. Bipolar Disord 2004, 6:204-212. 10.1111/j.1399-5618.2004.00110.x, 15117399.
81. Alloy LB, Abramson LY, Walshaw PD, Cogswell A, Grandin LD, Hughes ME, et al. Behavioral Approach System and Behavioral Inhibition System sensitivities and bipolar spectrum disorders: prospective prediction of bipolar mood episodes. Bipolar Disord 2008, 10:310-322. 10.1111/j.1399-5618.2007.00547.x, 18271911.
82. Franken IH, Muris P, Georgieva I. Gray's model of personality and addiction. Addict Behav 2006, 31:399-403. 10.1016/j.addbeh.2005.05.022, 15964149.
83. McElroy SL, Altshuler LL, Suppes T, Keck PE, Frye MA, Denicoff KD, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry 2001, 158:420-426. 10.1176/appi.ajp.158.3.420, 11229983.
84. World Advertising Research Center Ltd World Drink Trends 2005 Edition. 2005, World Advertising Research Center Ltd, World Advertising Research Center Ltd.
85. Norwegian Institute for Alcohol and Drug Research Alcohol and drugs in Norway 2008. Statens Institutt for Rusmiddelforskning/Norwegian Institute of Alcohol and Drug Research (SIRUS), Bryhni A, 1-123-2008, Norwegian Institute for Alcohol and Drug Research.
86. Sinclair JM, Latifi AH, Latifi AW. Co-morbid substance misuse in psychiatric patients: prevalence and association with length of inpatient stay. J Psychopharmacol 2008, 22:92-99. 10.1177/0269881107082029, 18187536.
87. Strakowski SM, DelBello MP, Fleck DE, Arndt S. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 2000, 48:477-485. 10.1016/S0006-3223(00)00900-8, 11018221.
88. Innamorati M, Pompili M, Lester D, Tatarelli R, Girardi P. Recreational drug use and suicidality among italian young adults. J Addict Dis 2008, 27:51-59. 10.1080/10550880802324796, 19042591.
89. Gentil AF, de Mathis MA, Torresan RC, Diniz JB, Alvarenga P, do Rosario MC, et al. Alcohol use disorders in patients with obsessive-compulsive disorder: the importance of appropriate dual-diagnosis. Drug Alcohol Depend 2009, 100:173-177. 10.1016/j.drugalcdep.2008.09.010, 19004577.
90. Limosin F, Loze JY, Philippe A, Casadebaig F, Rouillon F. Ten-year prospective follow-up study of the mortality by suicide in schizophrenic patients. Schizophr Res 2007, 94:23-28. 10.1016/j.schres.2007.04.031, 17574389.
91. Bulik CM, Thornton L, Pinheiro AP, Plotnicov K, Klump KL, Brandt H, et al. Suicide attempts in anorexia nervosa. Psychosom Med 2008, 70:378-383. 10.1097/PSY.0b013e3181646765, 18256339.
92. D'Souza DC, Perry E, MacDougall L, Ammerman Y, Cooper T, Wu YT, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology 2004, 29:1558-1572. 10.1038/sj.npp.1300496, 15173844.
93. Williamson S, Gossop M, Powis B, Griffiths P, Fountain J, Strang J. Adverse effects of stimulant drugs in a community sample of drug users. Drug Alcohol Depend 1997, 44:87-94. 10.1016/S0376-8716(96)01324-5, 9088780.
94. Arseneault L, Cannon M, Witton J, Murray RM. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004, 184:110-117. 10.1192/bjp.184.2.110, 14754822.
95. Dalmau A, Bergman B, Brismar B. Psychotic disorders among inpatients with abuse of cannabis, amphetamine and opiates. Do dopaminergic stimulants facilitate psychiatric illness?. Eur Psychiatry 1999, 14:366-371. 10.1016/S0924-9338(99)00234-5, 10683620.